DavidRByrdMD
General Surgery • Seattle, WABreast, Endocrine, Surgical Oncology (Other than Breast)
Associate Professor of Surgery, University Wash
Dr. Byrd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
Seattle, WA 98195Phone+1 206-606-1160
Education & Training
University of WashingtonResidency, Surgery, 1982 - 1987
Tulane University School of MedicineClass of 1982
Certifications & Licensure
WA State Medical License 1983 - 2026
TX State Medical License 1990 - 1992- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.John F Thompson, John Hyngstrom, Corrado Caracò, Jonathan S Zager, Tiina Jahkola
Annals of Surgical Oncology. 2023-07-01 - 28 citationsTherapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial., Jessica S Crystal, John F Thompson, John Hyngstrom, Corrado Caracò
JAMA Surgery. 2022-09-01 - 5 citationsAn In Vivo Model of Human Macrophages in Metastatic Melanoma.Valentin Voillet, Trisha R Berger, Kelly M McKenna, Kelly G Paulson, Wei Hong Tan
Journal of Immunology. 2022-08-01
Journal Articles
- Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaUpendra Parvathaneni, David M Koelle, David Byrd, Shailender Bhatia, Michi Shinohara, Clinical Cancer Research
Press Mentions
Fred Hutch Phase 1 Program Director, Dr. John Thompson, RetiresDecember 19th, 2024- Tip Sheet: New Insights on RSV and Malaria, Metastatic Breast Cancer Resources for Patients — and Fred Hutch at ASHDecember 5th, 2024
- Diagnosed With Thyroid Cancer, New Mom Counted the Days Until She Could Have Another ChildNovember 25th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
